Sarah Oliai

Cooley advised Logik.io, the company that reimagines configure, price and quote (CPQ) and consumerizes enterprise selling experiences, on its $25 million Series B funding to accelerate CPQ innovation and further expand company growth.

Cooley advised GeBBS Healthcare Solutions, a global provider of healthcare outsourcing solutions, and ChrysCapital, a top India-focused private equity firm, on the agreement for BPEA Private Equity Fund VIII (EQT Private Capital Asia) to acquire a controlling beneficial interest in GeBBS from ChrysCapital.

Cooley advised Encord, a data development platform for multimodal artificial intelligence, on its $30 million Series B financing.

Cooley advised video game studio Gardens Interactive on its $31.3 million Series A funding.

Cooley advised Jiangsu Hengrui Pharmaceuticals, one of the largest pharmaceutical companies in China, on its licensing of global rights (excluding Greater China) for the development, production and commercialization of three of its proprietary glucagon-like peptide-1 (GLP-1) drugs to Hercules CM Newco, a newly established Delaware company.